Page last updated: 2024-09-03

mk 0663 and Hemophilia A

mk 0663 has been researched along with Hemophilia A in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cavanaugh, PF; Matsumoto, AK	1
Curtis, SP; Eyster, ME; Giallella, KM; Melian, A; Mukhopadhyay, S; Reicin, AS; Shingo, S; Tsoukas, C	1

Reviews

1 review(s) available for mk 0663 and Hemophilia A

Article	Year
Etoricoxib. Drugs of today (Barcelona, Spain : 1998), 2004, Volume: 40, Issue:5 Topics: Arthritis; Clinical Trials as Topic; Cyclooxygenase 2; Etoricoxib; Hemarthrosis; Hemophilia A; Humans; Isoenzymes; Membrane Proteins; Pain; Prostaglandin-Endoperoxide Synthases; Pyridines; Spondylitis, Ankylosing; Sulfones	2004

Trials

1 trial(s) available for mk 0663 and Hemophilia A

Article	Year
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy. Blood, 2006, Mar-01, Volume: 107, Issue:5 Topics: Adolescent; Adult; Aged; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Headache; Hemarthrosis; Hemophilia A; Humans; Lactones; Male; Membrane Proteins; Middle Aged; Pyridines; Respiratory Tract Infections; Sulfones; Treatment Outcome	2006

Article

Year

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.

Blood, 2006, Mar-01, Volume: 107, Issue:5

Topics: Adolescent; Adult; Aged; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Headache; Hemarthrosis; Hemophilia A; Humans; Lactones; Male; Membrane Proteins; Middle Aged; Pyridines; Respiratory Tract Infections; Sulfones; Treatment Outcome

2006